US Stock MarketDetailed Quotes

XERS Xeris Pharmaceuticals

Watchlist
  • 2.670
  • +0.160+6.37%
Close Sep 9 16:00 ET
397.83MMarket Cap-6357P/E (TTM)

Xeris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
24.71%-10.35M
22.33%-20.3M
54.30%-47.02M
146.35%7.47M
17.71%-14.61M
33.31%-13.74M
46.00%-26.14M
-7.70%-102.89M
44.31%-16.12M
21.48%-17.75M
Net income from continuing operations
24.38%-15.01M
-12.75%-18.98M
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
16.06%-21.83M
Operating gains losses
----
----
1,148.84%3.16M
114.29%2K
----
----
----
-142.88%-301K
-101.77%-14K
380.25%227K
Depreciation and amortization
-6.21%3.15M
1.04%3.21M
3.88%13.16M
-6.97%3.26M
9.31%3.36M
9.83%3.36M
4.91%3.18M
574.19%12.67M
289.66%3.5M
850.77%3.07M
Deferred tax
210.96%749K
--307K
12.29%-1.25M
----
----
---675K
--0
---1.42M
----
----
Other non cash items
192.79%206K
-244.51%-2.79M
-182.46%-3M
68.28%-1.6M
-212.81%-361K
-104.17%-222K
-126.72%-811K
277.94%3.63M
-2,257.26%-5.05M
36.17%320K
Change In working capital
-398.68%-3.39M
59.35%-5.63M
82.09%-6.29M
692.72%17.83M
-355.78%-11.4M
120.90%1.13M
42.77%-13.86M
-396.52%-35.15M
-117.58%-3.01M
-206.12%-2.5M
-Change in receivables
-891.50%-5.03M
6,043.33%1.78M
37.44%-8.37M
304.38%6.77M
-793.36%-15.74M
126.76%635K
99.49%-30K
-114.43%-13.37M
-837.64%-3.31M
-39.18%-1.76M
-Change in inventory
69.53%-2.27M
38.90%-2.33M
-98.31%-14.8M
74.55%-1.4M
-30.09%-2.15M
-4,922.30%-7.43M
-2,331.21%-3.82M
-0.63%-7.47M
-142.08%-5.51M
-31.56%-1.66M
-Change in prepaid assets
-86.31%281K
-51.67%-1.86M
182.48%3.21M
280.34%2.04M
118.67%343K
337.78%2.05M
-2,012.07%-1.23M
-218.15%-3.89M
-130.71%-1.13M
-38.33%-1.84M
-Change in payables and accrued expense
-76.80%688K
25.32%-5.18M
146.21%6.44M
701.88%6.39M
90.79%4.02M
186.42%2.97M
39.85%-6.94M
-162.46%-13.93M
-106.78%-1.06M
-33.27%2.11M
-Change in other current liabilities
-90.76%302K
118.93%762K
113.24%818K
199.33%893K
--684K
--3.27M
23.75%-4.03M
---6.18M
---899K
--0
-Change in other working capital
848.01%2.63M
-45.18%1.2M
-33.70%6.42M
-64.72%3.14M
124.11%1.45M
-125.34%-352K
273.71%2.18M
12,671.43%9.68M
2,265.21%8.9M
634.71%647K
Cash from discontinued investing activities
Operating cash flow
24.71%-10.35M
22.33%-20.3M
54.30%-47.02M
146.35%7.47M
17.71%-14.61M
33.31%-13.74M
46.00%-26.14M
-7.70%-102.89M
44.31%-16.12M
21.48%-17.75M
Investing cash flow
Cash flow from continuing investing activities
-45.54%4.6M
55.32%-19.65M
-117.42%-6M
62.17%14.87M
118.44%14.66M
-28.78%8.45M
-754.84%-43.98M
-64.82%34.46M
-74.95%9.17M
-63.74%6.71M
Capital expenditure reported
74.35%-397K
31.09%-164K
-331.87%-2.26M
0.00%-132K
-96.02%-345K
-567.24%-1.55M
-1,587.50%-238K
51.71%-524K
-0.76%-132K
42.67%-176K
Net business purchase and sale
----
----
--0
----
----
----
----
--0
----
----
Net investment purchase and sale
-50.00%5M
55.45%-19.49M
-110.69%-3.74M
61.29%15M
117.86%15M
-17.36%10M
-752.85%-43.74M
-42.25%34.99M
635.71%9.3M
-63.40%6.89M
Cash from discontinued investing activities
Investing cash flow
-45.54%4.6M
55.32%-19.65M
-117.42%-6M
62.17%14.87M
118.44%14.66M
-28.78%8.45M
-754.84%-43.98M
-64.82%34.46M
-74.95%9.17M
-63.74%6.71M
Financing cash flow
Cash flow from continuing financing activities
18.53%659K
4,178.10%35.19M
-101.27%-1.61M
-102.51%-1.23M
61.50%-72K
79.35%556K
-101.10%-863K
367.84%127.47M
39,224.80%49.16M
-18,800.00%-187K
Net issuance payments of debt
--0
--38.17M
--0
--0
--0
--0
--0
--102.72M
--48.92M
--0
Net common stock issuance
-104.00%-51K
-297.91%-3.43M
-103.42%-1.01M
-133.33%-49K
-157.14%-72K
-733.33%-25K
-102.92%-863K
11.58%29.53M
87.57%-21K
---28K
Proceeds from stock option exercised by employees
22.20%710K
--459K
-30.50%581K
--0
--0
13.92%581K
--0
0.12%836K
8.16%318K
--0
Net other financing activities
----
----
78.89%-1.19M
----
----
----
----
-10,294.44%-5.61M
---60K
---159K
Cash from discontinued financing activities
Financing cash flow
18.53%659K
4,178.10%35.19M
-101.27%-1.61M
-102.51%-1.23M
61.50%-72K
79.35%556K
-101.10%-863K
367.84%127.47M
39,224.80%49.16M
-18,800.00%-187K
Net cash flow
Beginning cash position
20.93%66.92M
-43.26%71.67M
87.77%126.31M
-39.88%50.57M
-46.93%50.6M
-46.68%55.33M
87.77%126.31M
78.92%67.27M
41.38%84.11M
49.91%95.34M
Current changes in cash
-7.39%-5.09M
93.30%-4.76M
-192.54%-54.64M
-49.99%21.11M
99.76%-27K
43.83%-4.74M
-294.47%-70.98M
98.96%59.04M
442.41%42.21M
-173.62%-11.23M
Effect of exchange rate changes
----
----
--0
----
----
----
----
--0
----
----
End cash Position
22.20%61.83M
20.93%66.92M
-43.26%71.67M
-43.26%71.67M
-39.88%50.57M
-46.93%50.6M
-46.68%55.33M
87.77%126.31M
87.77%126.31M
41.38%84.11M
Free cash flow
29.73%-10.75M
22.41%-20.47M
52.34%-49.29M
145.16%7.34M
16.59%-14.96M
26.57%-15.29M
45.51%-26.38M
-7.03%-103.42M
44.11%-16.25M
21.76%-17.93M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 24.71%-10.35M22.33%-20.3M54.30%-47.02M146.35%7.47M17.71%-14.61M33.31%-13.74M46.00%-26.14M-7.70%-102.89M44.31%-16.12M21.48%-17.75M
Net income from continuing operations 24.38%-15.01M-12.75%-18.98M34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M16.06%-21.83M
Operating gains losses --------1,148.84%3.16M114.29%2K-------------142.88%-301K-101.77%-14K380.25%227K
Depreciation and amortization -6.21%3.15M1.04%3.21M3.88%13.16M-6.97%3.26M9.31%3.36M9.83%3.36M4.91%3.18M574.19%12.67M289.66%3.5M850.77%3.07M
Deferred tax 210.96%749K--307K12.29%-1.25M-----------675K--0---1.42M--------
Other non cash items 192.79%206K-244.51%-2.79M-182.46%-3M68.28%-1.6M-212.81%-361K-104.17%-222K-126.72%-811K277.94%3.63M-2,257.26%-5.05M36.17%320K
Change In working capital -398.68%-3.39M59.35%-5.63M82.09%-6.29M692.72%17.83M-355.78%-11.4M120.90%1.13M42.77%-13.86M-396.52%-35.15M-117.58%-3.01M-206.12%-2.5M
-Change in receivables -891.50%-5.03M6,043.33%1.78M37.44%-8.37M304.38%6.77M-793.36%-15.74M126.76%635K99.49%-30K-114.43%-13.37M-837.64%-3.31M-39.18%-1.76M
-Change in inventory 69.53%-2.27M38.90%-2.33M-98.31%-14.8M74.55%-1.4M-30.09%-2.15M-4,922.30%-7.43M-2,331.21%-3.82M-0.63%-7.47M-142.08%-5.51M-31.56%-1.66M
-Change in prepaid assets -86.31%281K-51.67%-1.86M182.48%3.21M280.34%2.04M118.67%343K337.78%2.05M-2,012.07%-1.23M-218.15%-3.89M-130.71%-1.13M-38.33%-1.84M
-Change in payables and accrued expense -76.80%688K25.32%-5.18M146.21%6.44M701.88%6.39M90.79%4.02M186.42%2.97M39.85%-6.94M-162.46%-13.93M-106.78%-1.06M-33.27%2.11M
-Change in other current liabilities -90.76%302K118.93%762K113.24%818K199.33%893K--684K--3.27M23.75%-4.03M---6.18M---899K--0
-Change in other working capital 848.01%2.63M-45.18%1.2M-33.70%6.42M-64.72%3.14M124.11%1.45M-125.34%-352K273.71%2.18M12,671.43%9.68M2,265.21%8.9M634.71%647K
Cash from discontinued investing activities
Operating cash flow 24.71%-10.35M22.33%-20.3M54.30%-47.02M146.35%7.47M17.71%-14.61M33.31%-13.74M46.00%-26.14M-7.70%-102.89M44.31%-16.12M21.48%-17.75M
Investing cash flow
Cash flow from continuing investing activities -45.54%4.6M55.32%-19.65M-117.42%-6M62.17%14.87M118.44%14.66M-28.78%8.45M-754.84%-43.98M-64.82%34.46M-74.95%9.17M-63.74%6.71M
Capital expenditure reported 74.35%-397K31.09%-164K-331.87%-2.26M0.00%-132K-96.02%-345K-567.24%-1.55M-1,587.50%-238K51.71%-524K-0.76%-132K42.67%-176K
Net business purchase and sale ----------0------------------0--------
Net investment purchase and sale -50.00%5M55.45%-19.49M-110.69%-3.74M61.29%15M117.86%15M-17.36%10M-752.85%-43.74M-42.25%34.99M635.71%9.3M-63.40%6.89M
Cash from discontinued investing activities
Investing cash flow -45.54%4.6M55.32%-19.65M-117.42%-6M62.17%14.87M118.44%14.66M-28.78%8.45M-754.84%-43.98M-64.82%34.46M-74.95%9.17M-63.74%6.71M
Financing cash flow
Cash flow from continuing financing activities 18.53%659K4,178.10%35.19M-101.27%-1.61M-102.51%-1.23M61.50%-72K79.35%556K-101.10%-863K367.84%127.47M39,224.80%49.16M-18,800.00%-187K
Net issuance payments of debt --0--38.17M--0--0--0--0--0--102.72M--48.92M--0
Net common stock issuance -104.00%-51K-297.91%-3.43M-103.42%-1.01M-133.33%-49K-157.14%-72K-733.33%-25K-102.92%-863K11.58%29.53M87.57%-21K---28K
Proceeds from stock option exercised by employees 22.20%710K--459K-30.50%581K--0--013.92%581K--00.12%836K8.16%318K--0
Net other financing activities --------78.89%-1.19M-----------------10,294.44%-5.61M---60K---159K
Cash from discontinued financing activities
Financing cash flow 18.53%659K4,178.10%35.19M-101.27%-1.61M-102.51%-1.23M61.50%-72K79.35%556K-101.10%-863K367.84%127.47M39,224.80%49.16M-18,800.00%-187K
Net cash flow
Beginning cash position 20.93%66.92M-43.26%71.67M87.77%126.31M-39.88%50.57M-46.93%50.6M-46.68%55.33M87.77%126.31M78.92%67.27M41.38%84.11M49.91%95.34M
Current changes in cash -7.39%-5.09M93.30%-4.76M-192.54%-54.64M-49.99%21.11M99.76%-27K43.83%-4.74M-294.47%-70.98M98.96%59.04M442.41%42.21M-173.62%-11.23M
Effect of exchange rate changes ----------0------------------0--------
End cash Position 22.20%61.83M20.93%66.92M-43.26%71.67M-43.26%71.67M-39.88%50.57M-46.93%50.6M-46.68%55.33M87.77%126.31M87.77%126.31M41.38%84.11M
Free cash flow 29.73%-10.75M22.41%-20.47M52.34%-49.29M145.16%7.34M16.59%-14.96M26.57%-15.29M45.51%-26.38M-7.03%-103.42M44.11%-16.25M21.76%-17.93M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg